Abossie, Ashenafi
Getachew, Hallelujah
Demissew, Assalif
Habtamu, Kassahun
Tsegaye, Arega
Zhong, Daibin
Wang, Xiaoming
Degefa, Teshome
Lee, Ming-Chieh
Zhou, Guofa
King, Christopher L.
Kazura, James W.
Yewhalaw, Delenasaw
Yan, Guiyun
Article History
Received: 23 March 2024
Accepted: 4 November 2024
First Online: 29 November 2024
Declarations
: <b>Ethics approval and consent to participate</b>The protocol was reviewed and approved by the National Research Ethics Review Committee (NRERC) of Ethiopia (Ref. no.: 10/31/2018) and Jimma University Institute of Health, Institutional Review Board (Reference No. IHRPGD/362/2). Permission was obtained from the relevant Buno Bedele and East Wollega health offices, and Arjo-Didessa Sugar Factory, Oromia regional state, Ethiopia. A written consent was obtained from the study participants and the parents and guardians of children. All malaria-positive index cases and positive study participants identified by microscopic examination of blood film and Rapid Diagnostic tests (RDT) at PCD clinics were treated as per the national malaria treatment guideline for free by health professionals.
: Not applicable.
: The authors declare no competing interests.